Home

J B Chemicals & Pharmaceuticals Ltd PE Ratio

Image

J B Chemicals & Pharmaceuticals Ltd

NSE: JBCHEPHARM

PE

44.8

Last updated on: Jan 15, 2025

Key Highlights

  • The P/E Ratio of J B Chemicals & Pharmaceuticals Ltd is 44.8 as of 15 Jan 15:30 PM .
  • The P/E Ratio of J B Chemicals & Pharmaceuticals Ltd changed from 14.4 on March 2020 to 46.3 on March 2024 . This represents a CAGR of 26.31% over 5 years.
  • The Latest Trading Price of J B Chemicals & Pharmaceuticals Ltd is ₹ 1763 as of 15 Jan 16:01 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 21.0 to 40.0 in 5 years. This represents a CAGR of 13.75%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.4. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 36.9 in 2024.

Historical P/E Ratio of J B Chemicals & Pharmaceuticals Ltd

No data available

Company Fundamentals for J B Chemicals & Pharmaceuticals Ltd

Image

J B Chemicals & Pharmaceuticals Ltd

NSE: JBCHEPHARM

Share Price

₹ 1763.25

2.80 (0.16%)

stock direction

Last updated on: Jan 15, 2025

Market Price of J B Chemicals & Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring J B Chemicals & Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
14 Jan 20251760.45
13 Jan 20251777.65
10 Jan 20251823.35
09 Jan 20251864.9
08 Jan 20251899.9
07 Jan 20251895.7
06 Jan 20251828
03 Jan 20251866.2
02 Jan 20251862.85
01 Jan 20251877.75

SWOT Analysis Of J B Chemicals & Pharmaceuticals Ltd

Strength

4

che

Weakness

2

che

Opportunity

0

che

Threats

1

che

BlinkX Score for J B Chemicals & Pharmaceuticals Ltd

Asset Value vs Market Value of J B Chemicals & Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of P/E Ratio

Company
leftMarket Capright
J B Chemicals & Pharmaceuticals Ltd27383
Sun Pharmaceuticals Industries Ltd424382
Divis Laboratories Ltd159224
Cipla Ltd116943
Dr Reddys Laboratories Ltd111588

PE Ratio of J B Chemicals & Pharmaceuticals Ltd Explained

``

27383

Market cap

611

Earnings

44.8X

PE Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of J B Chemicals & Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of J B Chemicals & Pharmaceuticals Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of J B Chemicals & Pharmaceuticals Ltd

No data available

* All values are in %

About J B Chemicals & Pharmaceuticals Ltd

  • J B Chemicals & Pharmaceuticals (JBC) was originally promoted and incorporated in Maharashtra by J B Mody as J B Mody Chemicals & Pharmaceuticals in December 18th, 1976.
  • The Company is engaged in the business of manufacturing and marketing of diverse range of pharmaceuticals formulations, herbal remedies and APIs.
  • The company has manufacturing units at Thane, Belapur, Ankleshwar, Panoli and Daman.
  • The bulk drug plant at Panoli and formulation plant at Daman became operational in Apr.'95.
  • Products like metrogyl, rantac (a ranitidine-based formulation), and nicardia (a cardiac care medicine) form a significant part of the company's sales.

J B Chemicals & Pharmaceuticals Ltd News Hub

J B Chemicals & Pharmaceuticals Ltd soars 1.09%, Gains for third straight session

J B Chemicals & Pharmaceuticals Ltd is up for a third straight session in a row. The stock is quotin

Read more

2024-08-14 00:00:00

J B Chemicals & Pharmaceuticals allots 11,500 equity shares under ESOS

J B Chemicals & Pharmaceuticals has allotted 11,500 equity shares under ESOS on 08 August 2024. Cons

Read more

2024-08-08 00:00:00

J B Chemicals & Pharmaceuticals consolidated net profit rises 24.25% in the June 2024 quarter

Net profit of J B Chemicals & Pharmaceuticals rose 24.25% to Rs 176.83 crore in the quarter ended Ju

Read more

2024-08-08 00:00:00

J B Chemicals & Pharmaceuticals allots 69,850 equity shares under ESOS

J B Chemicals & Pharmaceuticals has allotted 69,850 equity shares under ESOS on 26 August 2024. Cons

Read more

2024-08-27 00:00:00

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of J B Chemicals & Pharmaceuticals Ltd

What is the current PE Ratio of J B Chemicals & Pharmaceuticals Ltd?

The Current PE Ratio of J B Chemicals & Pharmaceuticals Ltd is 44.81 as on 15 Jan 2025.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 15 Jan 2025.

What was the PE Ratio of J B Chemicals & Pharmaceuticals Ltd last year?

The PE Ratio of J B Chemicals & Pharmaceuticals Ltd was 37.21 last year, now the PE ratio is 44.81, showing a year-on-year growth of 20.4%.

What does the PE Ratio of J B Chemicals & Pharmaceuticals Ltd indicate about its stock?

The PE Ratio of J B Chemicals & Pharmaceuticals Ltd is 44.81. This ratio indicates that investors are willing to pay 44.81 times the earnings per share for each share of J B Chemicals & Pharmaceuticals Ltd.

What is the PE Ratio Growth of J B Chemicals & Pharmaceuticals Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of J B Chemicals & Pharmaceuticals Ltd grew by 20.4% whereas, the EPS ratio grew by -1.3.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions